CSat Investment Advisory’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
CSat Investment Advisory's ONCE Position: Q4 2019 in Review
CSat Investment Advisory sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 1,351 shares — an estimated $131K sold.
CSat Investment Advisory first reported a position in ONCE in Q2 2019 and held it in 2 quarters. The position peaked at $131K in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- CSat Investment Advisory reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- CSat Investment Advisory sold 1,351 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $131K.
- CSat Investment Advisory first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
- CSat Investment Advisory's Spark Therapeutics, Inc. Common Stock position peaked at $131K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on CSat Investment Advisory's 13F filing for Q4 2019, filed 13 Feb 2020.